ADPT
Price
$25.96
Change
+$0.68 (+2.69%)
Updated
Oct 14, 11:01 AM (EDT)
Capitalization
4.55B
22 days until earnings call
Intraday BUY SELL Signals
ARRY
Price
$3.35
Change
-$0.22 (-6.16%)
Updated
Oct 14, 12:44 PM (EDT)
Capitalization
589.85M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADPT vs ARRY

ADPT vs ARRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADPT vs. ARRY commentary
Oct 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and ARRY is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADPT with price predictions
Oct 13, 2026

ADPT in downward trend: price dove below 50-day moving average on October 12, 2026

ADPT moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend. In 41 of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ADPT moved out of overbought territory on September 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 22 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ADPT as a result. In 69 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The Moving Average Convergence Divergence Histogram (MACD) for ADPT turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 43 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +9.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADPT advanced for three days, in 235 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

ADPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 173 of 188 cases where ADPT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ADPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (31.847) is normal, around the industry mean (72.578). P/E Ratio (0.000) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.001) among similar stocks. P/S Ratio (13.966) is also within normal values, averaging (9.775).

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

A.I.Advisor
a Summary for ARRY with price predictions
Oct 13, 2026

ARRY sees MACD Histogram crosses below signal line

ARRY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 39 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARRY as a result. In 79 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for ARRY entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ARRY's RSI Indicator exited the oversold zone, 29 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +5.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARRY advanced for three days, in 202 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

ARRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. ARRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ARRY's P/B Ratio (15.432) is slightly higher than the industry average of (4.841). P/E Ratio (56.911) is within average values for comparable stocks, (100.974). Projected Growth (PEG Ratio) (0.399) is also within normal values, averaging (1.699). Dividend Yield (0.000) settles around the average of (0.013) among similar stocks. P/S Ratio (0.543) is also within normal values, averaging (5.133).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

FUNDAMENTALS RATINGS
ADPT vs ARRY: Fundamental Ratings
ADPT
ARRY
OUTLOOK RATING
1..100
8757
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3690
P/E GROWTH RATING
1..100
10022
SEASONALITY SCORE
1..100
1250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADPT's Valuation (45) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ARRY (97) in the Biotechnology industry. This means that ADPT’s stock grew somewhat faster than ARRY’s over the last 12 months.

ADPT's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as ARRY (100) in the Biotechnology industry. This means that ADPT’s stock grew similarly to ARRY’s over the last 12 months.

ADPT's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as ARRY (100) in the Biotechnology industry. This means that ADPT’s stock grew similarly to ARRY’s over the last 12 months.

ADPT's Price Growth Rating (36) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ARRY (90) in the Biotechnology industry. This means that ADPT’s stock grew somewhat faster than ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (22) in the Biotechnology industry is significantly better than the same rating for ADPT (100) in the Hospital Or Nursing Management industry. This means that ARRY’s stock grew significantly faster than ADPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTARRY
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
COMPARISON
Comparison
Oct 14, 2026
Stock price -- (ADPT: $25.28 vs. ARRY: $3.57)
Brand notoriety: ADPT: Notable vs. ARRY: Not notable
ADPT represents the Medical Specialties, while ARRY is part of the Alternative Power Generation industry
Current volume relative to the 65-day Moving Average: ADPT: 83% vs. ARRY: 82%
Market capitalization -- ADPT: $4.55B vs. ARRY: $589.85M
ADPT [@Medical Specialties] is valued at $4.55B. ARRY’s [@Alternative Power Generation] market capitalization is $589.85M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $3.39K to $270.64B. The average market capitalization across the [@Medical Specialties] industry is $20.78B. The average market capitalization across the [@Alternative Power Generation] industry is $5.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green while ARRY’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • ARRY’s FA Score: 1 green, 4 red.
According to our system of comparison, ADPT is a better buy in the long-term than ARRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while ARRY’s TA Score has 4 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 5 bearish.
  • ARRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Medical Specialties) experienced а -6.02% price change this week, while ARRY (@Alternative Power Generation) price change was -12.07% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.57%. For the same industry, the average monthly price growth was +1.42%, and the average quarterly price growth was +38.10%.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -6.87%. For the same industry, the average monthly price growth was -3.20%, and the average quarterly price growth was -34.94%.

Reported Earning Dates

ADPT is expected to report earnings on Nov 05, 2026.

ARRY is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical Specialties (-3.57% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Alternative Power Generation (-6.87% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

View a ticker or compare two or three
ADPT
Daily Signal:
Gain/Loss:
ARRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BOTZ34.960.06
+0.17%
Global X Robotics & Artificial Intelligence ETF (BOTZ)
IDUB27.190.02
+0.07%
Aptus International Enhanced Yield (IDUB)
DEFR26.170.02
+0.06%
Aptus Deferred Income ETF
BDCX18.87N/A
N/A
ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN (BDCX)
AAPW41.48-0.08
-0.20%
Roundhill AAPL WeeklyPay ETF (AAPW)

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
-1.13%
AXON - ADPT
56%
Loosely correlated
-0.26%
PSNL - ADPT
55%
Loosely correlated
+0.32%
NTRA - ADPT
55%
Loosely correlated
-0.53%
VCYT - ADPT
54%
Loosely correlated
-2.07%
ARRY - ADPT
50%
Loosely correlated
-0.83%
More